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Abstract: 
Iron deficiency anemia In early life produces profound changes in both in vivo and In vitro evaluations of 
dopamine (DA) functioning. This study employed both behavioral and biochemical approaches to examine the 
biological bases of alterations in striate! DA metabolism seen in Iron-deficient rats. The purpose was to 
determine whether the DA transporter (DAT) was functionally altered in postweaning iron deficiency. Male and 
female 21-d-old Sprague-Dewley rats (n = 40) were fed either an iron-deficient (ID) diet (3 mg Fe/kg diet) or a 
control (CN) diet (35 mg Fe/kg diet) for 4 wk before behavioral testing. Motor activity responses to graded 
doses (3.75-30 mg/kg body) of the DA uptake inhibitor, cocaine, were significantly blunted in iron-deficient 
rats with a 50% higher half-maximal effective dose (ED50) in both males and females (CN-female, 7.1 ± 0.9 
mg/kg; ID-female, 11.2 ± 1.3 mg/kg; CN-male, 12.0 ± 0.7 mg/kg; and ID-male, 17.0 ± 1.8 mg/kg). Radioligand 
binding assays with 
3
H-1-(2- (diphenylmethoxy)-ethyl)-4-(3-phenylpropyl) plperazine (
3
H-GBR12935) 
demonstrated that Iron deficiency did not alter the affinity of the ligand for the DAT but did significantly 
decrease the density of the transporter by 30% in caudate putamen and 20% In nucleus accumbens. Iron 
deficiency also significantly decreased 
3
H-DA uptake into striatal synaptosomes, but did not affect release of 
DA with potassium chloride stimulation. These experiments provide supporting evidence that elevated levels of 
extracellular DA in the striatum of Iron-deficient rats is likely to be the result of decreased DAT functioning and 
not increased rates of release. 
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Article: 
Iron deficiency is one of the most common nutritional disorders in the world, affecting nearly two billion people 
(W1-10/FAO, 1998). Symptoms of iron deficiency include lethargy, lack of concentration and decreased 
cognitive and attentional processes (Idjadinata and Pollitt 1993, Lozoff and Brittenham 1986, Pollitt 1993, 
Walter 1993). There is evidence that iron plays a role in neurobiological processes, although the exact 
neurobiological mechanism(s) remains unknown. Various studies have proposed changes in neurotransmitter 
metabolism (Beard et al. 1994, Chen et al. 1995, Youdim et al, 1989), myelin formation (Larkin and Rao 1990) 
and hippocampal functioning (Rao et al. 1999). Recent studies in both humans and rodents clearly demonstrate 
that in early life, the brain is quite susceptible to iron deficiency (Erikson et al. 1997, Kwik-Uribe et al. 1999, 
Pinero et al. 2000, Ran et al. 1999). Although the bulk of the evidence in humans suggests an irreversible 
alteration in neurodevelopment (Lozoff et al. 1998), the recent human studies of auditorily evoked potential 
changes are consistent with alterations in both myelination and neurochemistry (Roncagliolo et al. 1998). 
 
In rats, postweaning iron deficiency produces a substantial decrease in brain iron concentration that is reversible 
with iron repletion (Erikson et al. 1997, Pinero et al. 2000). Furthermore, iron deficiency-related decreased 
brain iron concentration has been linked to altered dopaminergic functioning (Chen et al. 1995,Nelson et al. 
1997, Youdim et al. 1989). The effects of iron deficiency on dopamine (DA)
2
 metabolism include decreased D2 
receptor density in caudate putamen (CP) (Erikson et al, unpublished data, Youdim et al. 1983) and increased 
extracellular DA in the CP (Beard et al. 1994, Chen et al. 1995, Nelson et al. 1997). Behavioral consequences of 
Iron deficiency-related alterations in striate DA function include altered locomotor activity (Glover and Jacobs 
1972, Hunt et al. 1994, unpublished observations from our laboratory). It is important to note that these 
alterations in DA metabolism are associated with decreased brain iron concentration and not anemia per se 
(Ashkenazi et al. 1982, Nelson et al, 1997, Youdim at al. 1989) and may be reversible with iron therapy (Nelson 
et al. 1997, Youdim or al. 1981). 
 
Approximately 80% of extracellular DA is recycled into presynaptic neurons through a reuptake Na
+
 
cotransporter, a 70-kDa protein that is both phosphorylated and glycosylated (Ciliax et al. 1995, Miller et al. 
1997). The DA transporter (DAT) is a member of the family of Na
+
,Cl
-
-dependent transporters whose 
regulation includes both chronic and acute regulatory factors (Mash and Staley 1997, Reith et al. 1997). It is 
important to recall that in vivo microdialysis experiments clearly indicated the possibility of a defect in DA 
uptake in iron-deficient rats (Nelson et al. 1997). 
 
Our overall hypothesis is that iron deficiency—related increased extracellular DA in the striatum is linked 
directly to decreased DAT activity. Therefore, we tested this hypothesis from behavioral [half-maximal dose 
(ED50), cocaine-induced hyperlocomotionl, functional (synaptosornal 
3
H-DA uptake) and biochemical [
3
H-1-(2-
(diphenylmethoxy)-ethyl)-4-(3- phenylpropyl) piperazine (
3
H-GBR12935) ligand binding] perspectives. 
 
MATERIALS AND METHODS 
Animals 
Male and female 21-d-old Sprague-Dawley rats (Harlan Sprague Dawley, Indianapolis, IN) were randomly 
divided into two dietary treatment groups as follows: control (CN; 35 mg Fe/kg diet, a = 32 males and females) 
and iron-deficient (ID; 3 mg Fe/kg diet, n 32 males and females). These diets were prepared as described 
previously (Pinero et al. 2000). Rats had free access to food and water 24 h/d, and lights were turned off 
between 1800 and 0600 h. The room temperature was maintained at 25 ± 1°C. After 4 wk of dietary treatment, 
behavioral testing was conducted. The Pennsylvania State University Animal Care and Use Committee 
approved all animal procedures. 
 
ED50 cocaine experiment and locomotor activity 
Locomotor activity was measured using a Digiscan Animal Activity Monitor, model RXYZCM (Omnitech 
Electronics, Columbus, OH) as described previously (Morse et al. 1999a). The apparatus consisted of a set of 
four identical 40 x 40 x 30.5 cm Plexiglas boxes with vertical and horizontal infrared sensors. The flooring was 
an elevated acrylic platform with equally spaced holes (4 X 4 X 1.5 cm in diameter). Data were collected by 
virtue of rat movements breaking a beam of light between photocells and were logged automatically into the 
computer and analyzed with the Digiscan software. All testing was begun between 0900 and 1100 h in the light 
cycle, although the testing boxes themselves were dark. A 2-d behavioral testing protocol was implemented. On 
d 1, rats from each diet and sex group (n = 5) were injected intraperitoneally with saline (1 mL/kg body) and 
immediately placed in the center of the activity monitor. Locomotion was measured for 30 mm in six 5-min 
intervals or bins of data. The index of locomotor activity analyzed for this report was total distance traveled 
(cm). On d 2, rats from the previous day were injected with one of four doses of cocaine (3.75, 7.5, 15 or 30 
mg/kg body) and locomotor activity measured as on the preceding day. The ordering of the dose was random. 
 
This protocol was repeated until all rats were tested (n = 5 for each cocaine dose per group). The ED50 for 
cocaine (the dose necessary to increase total distance by 50%) was calculated using a LOG LOGIT 
transformation of the data followed by regression analysis. 
 
Tissue. Within 2 d of having completed the behavior testing protocol, the rats were killed by decapitation, livers 
removed for nonheme iron determination and brains rapidly removed for uptake experiments or ligand binding 
assays. All rats were killed between 0900 and 1100 h. Blood was collected from the trunk of the rats, 
hemoglobin and hematocrit measured on fresh blood, and plasma obtained by centrifugation as detailed 
elsewhere (Pinero et al. 2000). The plasma was frozen at -20°C until it was analyzed for Fe and total iron-
binding capacity (TIBC) by established procedures (Chen et al. 1995). Transferrin saturation was calculated as 
serum Fe/TIBC x 100. 
 
 
Synaptosomal 
3
H-DA uptake and release experiments 
Striatal synaptosome preparation. Striata were dissected on an ice-cold aluminum block, weighed and 
homogenized in 20 volumes of ice-cold 0.32 mol/L sucrose, pH 7.4, using a teflon/glass homogenizer 
(Heidolph, Polyscience, Niles, IL). Homogenates were centrifuged at 2000 x g for 10 min at 4°C. The pellets 
were discarded and the supernatants were centrifuged at 20,000 X g for 15 rain at 4°C. The second pellet was 
resuspended in ice-cold Krebs-Ringer HEPES (KRH: 118 mmol/L NaCI, 4.7 mmoVL KCl, 1.18 mmoVL 
MgSO4, 1,2 mmol/L KH5PO4, 10 mmol/L HEPES, 5.6 mmol(L glucose, 2.5 mmol/L CaC12) pH 7.4, containing 
10 μmol/L pargyline (RBI, Natick, MA). 
 
Uptake experiments. Three uptake experiments were conducted using the following striate synaptosomes: 5-
mm uptake, half-maximal dose of the drug (cocaine) for in vitro effects (IC50), and Km and Vmax assays. Assay 
tubes contained 200 μL of synaptosomal suspension, 50 μL of KRH and 50 μL of cocaine solution (IC50 cocaine 
experiment, 10
-5
,10
-8
 mol(L final concentration). Tubes were preincubated for 10 mm at 37°C in a water bath, 
3
H-DA (NEN Life Sciences, Boston, MA) added and incubated for 5 min. The Km and Vmax experiments used 
3
H-DA concentrations ranging from 5 to 200 nmol/L. All other uptake experiments used 100 nmol/L 
3
H-DA. 
The reaction was terminated by the addition of ice-cold KRH to tubes and rapid filtration through GF/F 
Whatman glass-fiber filters (Kent, UK) on a Millipore (Bedford, MA) sampling manifold. Filters were washed 
twice with 3 mL ice-cold KRH and placed in scintillation vials; 5 mL scintillation cocktail (Ecoscint, National 
Diagnostics, Atlanta, GA) was added. Vials were counted on a Beckman liquid scintillation counter (LS-3801, 
Beckman Instruments, Irvine, CA) 24 h later. Nonspecific uptake was determined by incubating tubes from 
each group at 4°C. The protein content was determined using a micro-Lowry procedure (P5656 Sigma 
Chemical, Natick, MA) modified for use on 96-well plates and with 50 μL of sample. Uptake experiments were 
repeated three times using synaptosomes from two rats per group with each preparation of synaptosomes; thus a 
total of six independent observations were made for uptake and release experiments. 
 
Release experiments. Striatal synaptosomes were prepared as above and incubated with 100 nmol/L 
3
H-DA for 
10 mm at 37°C. Synaptosomal suspensions equaling 100 Ag protein were loaded into chambers of a Brandel 
SF-12 (Rockville, MD) superfusion apparatus. KRH buffer (4.7 mmol(L KCl) was perfused through the 
chambers (1 mL/min) for 5 min to establish baseline, and one of four concentrations of KRH (15, 30, 60 or 120 
mmol/L KCI) was perfused for 2 mm to elicit 
3
H-DA release. The experiments were terminated by perfusing 
deionized distilled water through the chambers, thereby lysing the synaptosomes and releasing the remaining 
3
H-DA. Scintillation vials collected samples at 1-min intervals, scintillation cocktail was added and vials 
counted 24 h later on a Beckman liquid scintillation counter (LS 3801, Beckman Instruments). Experiments 
were repeated three times with synaptosomes prepared from two rats per group for each experiment. 
 
3
H-GBR 12935 ligand binding
 
Brains from rats in the behavior protocol were dissected on an ice-cold aluminum block into the following four 
brain regions: prefrontal cortex (PFC), CP, nucleus accumbens (NA) and ventral midbrain (VMB, composed of 
both the ventral tegmentum area and the substantia nigra). These regions represent the cell bodies and terminal 
fields of the nigrostriatal, mesolimbic and mesocortical dopaminergic tracts. Membrane fractions were prepared 
as follows: brain regions were weighed and ice-cold 0.32 mol/L sucrose, pH 7.4, added to tubes (10 volumes for 
PFC and VMS, 20 volumes for CP and NA). Brain tissues were homogenized with a teflon/glass homogenizer 
(Heidolph, Polyscience), and the homogenates were centrifuged at 41,000 X g for 20 min at 4°C. The 
supernatant was decanted and the pellet resuspended with 300 μL (CP and NA) or 600 μL (PFC and VMB) of 9 
g/L saline. This washing procedure was repeated three times. Binding reactions were conducted in microtiter 
plates (CoStar, Corning, NY) as follows: resuspended membrane pellet (25 μL), sodium phosphate buffer (100 
mmol/L Na2HPO4, 120 mmol/L NaCl, 0.2 mmol/L ZnC12, pH 7.5, 25 μL) was added to duplicate tubes, 10 μL 
3
H-GBR 12935 added to all tubes, and 10 μL l-[2-(bis [4-Fluorophenyll-methoxyethyll]-4-(3-phenylpropyl]-
piperazine (GBR 12909; RBI) added to one tube of each sample to determine nonspecific binding. Incubation 
reactions had a final volume of 70 μL, and final concentrations of 
3
H-GBR 12935 and GBR-l2909 were 8 
nmol/L and 1 μmol/L, respectively. Samples were incubated for 1 h at room temperature, filtered onto GF/B 
Whatman filter paper, placed in scintillation vials and 5 mL scintillation cocktail added. Samples were counted 
on a Beckman liquid scintillation counter (LS 3801, Beckman Instruments) 24 h later. Protein contents were 
determined using the micro-Lowry assay. 
 
 
Iron analysis 
Total iron concentration of brain region homogenates from all rats was determined according to our standard 
laboratory method using acid digestion and analysis with atomic absorption spectrophorometry (Erikson et al. 
1997). 
 
Statistical analysis 
Data were analyzed using the SAS system for Windows v6.12 statistical analysis package (SAS, Cary, NC). 
Data were examined for normality of distribution and presence of outliers, ANOVA with repeated-measures 
factors (brain regions) and between-groups factors was used to test for interactions between dietary treatments 
and sex for ligand binding data. Two-way ANOVA was used to test effects of dietary treatment and sex on 
hematologic variables, liver nonheme iron and behavioral data, Tukey's post-hoc test was used to evaluate mean 
differences, The α-level for the analyses was set at P < 0.05. Omega squared (ω
2
) calculations were performed 
to estimate the magnitude of the effect of iron deficiency on certain dependent variables (Myers and Well 
1995). 
 
RESULTS 
ED50 cocaine experiment. Both male and female rats fed the ID diet were iron deficient and anemic as 
indicated by the significantly lower hemoglobin, hematocrit, plasma transferrin saturation and liver nonheme 
iron concentration (Table 1). Iron-deficient rats of both sexes moved significantly less than control rats in the 
naive testing condition of saline injection (P < 0.001, Fig. 1). Increasing doses of cocaine were associated with 
significant increases in locomotion in all rats, although iron-deficient rats were clearly less responsive than 
control rats at all doses (P < 0.001) and maintained the 50% deficit in movement regardless of the level of 
blockade of DA uptake. Female rats in both dietary treatments exhibited more motor activity than male rats, and 
cocaine did not show a differential effect on iron-deficient rats of one sex compared with the other. Analyses of 
these dose-response curves via LOGIT-LOG transformation and computation of the ED50 were performed to 
quantify the apparently right-shifted curves. These calculations showed an attenuated response in both male and 
female ID rats with significant independent effects of iron deficiency and sex on the ED50 dose of cocaine (F1, 4 
= 19.6, P = 0.015 and F1, 4 = 18.2, P 0.02, respectively, Table 2). 
 
Uptake experiments. The 5-min uptake of DA and the Vmax were significantly lower in striate synaptosomes of 
male and female iron-deficient rats compared with control rats (Table 2). Analysis of DA uptake at 30 and 60 s 
showed no effect of iron deficiency, hut uptakes at 90 and 120 s were 84 and 77% of control synaptosomal 
uptake (P < 0.05, data not shown). There was no effect of iron deficiency on the apparent Km for uptake of DA 
(Table 2). The IC50 experiments determined the effect of iron deficiency on the ability of cocaine to inhibit the 
synaptosomal uptake of DA (Table 2). Synaptosomes from the striatum from both iron-deficient male and 
female rats required ~6 μmol/L cocaine to inhibit 50% of the DA uptake compared with ~3 μmol/L cocaine in 
synaptosomes from control rats (P < 0.001). Because the synaptosomes from iron-deficient rats took up only 
~50% as much DA as control synaptosomes to begin with, this amounts to a more than fourfold higher amount 
of cocaine necessary to achieve the same absolute suppression of DA uptake. 
 
 
Release experiments. Iron deficiency did not significantly affect KCI-evoked 
3
H-DA release from striate 
synaptosomes compared with synaptosomes from control rats when doses of KCl from 15 to 120 mmot/L were 
tested (data not shown). That is, there were similar percentages of the intrasynaptosomat pool of DA released in 
iron-deficient and control synaptosomes at each concentration of KCI. For example, at 120 mmol/L KCl 
stimulation, there was 68% release of DA above baseline in control synaptosomes and a 72% release above 
baseline in iron-deficient synaptosomes. 
 
3
H-GBR 12935 ligand binding. Radioligand binding assays were performed to determine the affinity and 
density of DAT in isolated membranes for a highly specific ligarld. Scat-chard analyses were performed 
utilizing GBR 12935 concentrations that ranged from 1 pmolfL to 1 μmol/L and revealed a significant effect of 
iron deficiency on Bmax (8.2 ± 0.8 vs. 12.9 ± 1.1 pmol/mg of membrane protein, P < 0.01) but not Kd (8,1 ± 0.55 
vs. 8.3 ± 0.69 nmol/L, P = 0,88) of the DAT for its ligand. 
 
 
Because there was no effect of iron deficiency on apparent affinity, a concentration of 16 nmol/L 
3
H-GBR 
12935, twice the apparent Kd, was used to examine Bmax in four brain regions (Fig. 2). The effect of iron 
deficiency on 
3
H-GBR 12935 binding in all four brain regions examined was significant (P = 0.0021, ω
2
 = 0.21) 
as was the expected variation among brain regions (P < 0.0001), with CP > NA >> PFC > VMB (Fig. 2). In 
addition, iron deficiency did not affect all regions in both sexes similarly because there was a significant 
interaction of dietary treatment and brain region with sex of the rats (P < 0.001). Iron-deficient males had 
significantly lower Bmax in striatum (CP, P = 0.035), whereas both sexes were similarly and significantly 
affected by iron deficiency in the NA (P = 0.002). The terminal field of the mesocortical track, the PFC, 
actually had a significant 18% higher DAT density in female iron-deficient rats (P = 0.046) compared with 
control females. The VMB is comprised of the ventral tegmenturn area and the substantia nigra, and was 
sensitive to effects of iron deficiency only in females (P = 0.032). 
 
 
 
Brain region iron concentrations. Iron deficiency for 4 wk caused a significant decline in iron concentration in 
nearly all four brain regions examined (Fig. 3; F1, 16 = 33.7, P < 0.0001). The greatest drop in brain iron 
concentration was in the cell bodies of the VMB (F3, 64 = 13,8, P = 0.001) (estimated ω
2
 = 0.59) (Fig. 3), 
although significantly lower brain iron concentrations were also observed in CP and PFC (F3, 64 = 12.2, P < 
0,001and F3, 64 = 11.9, P < 0.001, respectively). It is important to note that the iron concentration was not 
affected in the NA in female rats with this dietary protocol, whereas the iron concentration in this region in iron-
deficient male rats was significantly(P < 0.05) lower than in controls. 
 
In an attempt to examine the relationship of systemic iron status to brain iron status, we correlated liver 
nonheme iron concentration with regional brain iron concentration and observed a significant correlation of 
liver Fe with VMB Fe (Fig. 4; r = 0.462, P < 0.0002) when there was some depletion of liver iron (e,g., the liver 
iron concentration was <400 μmol/g). There was no relationship between these two variables in control rats; 
thus the nature of the curve relating regional brain iron to liver iron stores remains somewhat speculative. There 
was no relationship between liver iron and regional brain iron concentration in other brain regions. Within the 
brain, we observed significant correlations of VMB (substantia nigra and ventral tegmentum) cell body iron 
with regional iron concentrations in the terminal fields of these Dopaminergic tracts in striatum (r 0.41, P = 
0.022) and PFC (r = 0.45, P = 0.015). 
 
DISCUSSION 
These experiments demonstrate that iron deficiency alters both in vivo and in vitro functioning of the DAT in 
rat striatum. These alterations due to iron deficiency were brain region specific (occurring in striatum not PFC) 
and affected males more dramatically than females. This work thus extends the previous observations that iron 
deficiency is associated with a decreased D2 receptor density (Ashkenazi et al, 1982, Youdim et al. 1983) and 
increased extracellular DA (Beard et al. 1994, Nelson et al. 1997). 
 
The current observations of attenuated in vivo and in vitro responses to cocaine also provide evidence that 
increased extracellular DA in iron deficiency is due primarily to altered clearance (Nelson et al. 1997). 
Synaptosomal release data from the current experiment are not consistent with an increased release of DA that 
is large enough to account for the observations made in vivo (Fig. 3); nor is it likely that the elevated DA is the 
result of increased DA synthesis because tyrosine hydroxylase activity was modestly decreased, not increased 
(unpublished observations). The most obvious explanation for this increased extracellular DA is that iron defi-
ciency affects DA reuptake into the presynaptic membrane by altering DAT functioning because this is the 
route of removal of > 70% of the extracellular DA from the synaptic space. Although there is no known direct 
role of iron for synthesis and/or regulation of the DAT, there are possible avenues of effect that involve gene 
regulation, post-translational modification, second messenger phosphorylation reactions or perhaps direct 
interactions with the ligand receptor site. 
 
One of the key regulators of the DAT is the activation of the D2 autoreceptor on the presynaptic membrane 
(Dickinson et al. 1999, Meiergerd et al. 1993). Increased agonist binding to this receptor increases the DAT 
activity (Meiergerd et al. 1993). Conversely, in D2 receptor—deficient mice, in vivo voltammetry demonstrated 
that exogenous DA clearance was attenuated, suggesting altered DA uptake (Dickinson et al. 1999). Both of the 
aforementioned studies also demonstrated that the effect of the D2 receptor occupancy on extracellular DA 
levels was not due to its effect on DA release. Thus, the down regulation of the D2 receptor observed numerous 
times [see review of Youdim et al. (1989)] in the striatum of iron-deficient rats might also play an important 
mechanistic role in the decreased functioning of the transporter. 
 
A second novel finding in the current studies is the observation that the dopaminergic system of female rats 
responds differently to iron deficiency than does the dopaminergic system of male rats. Others have 
demonstrated that female rats are more sensitive to cocaine than male rats and have a greater DAT density in 
striatum' (Morissette and DiPaulo 1993, Post et at. 1987). The current studies replicate the increased sensitivity 
(IC50) of females compared with males because female rats required significantly less cocaine than males to 
elicit a 50% increase in locomotor activity. We showed previously that sex and strain of highly inbred strains of 
mice are strong determinants of the biologic responses to iron deficiency in early life (Morse et al. 1999a and 
1999b). Although it appears that both male and female rats have similar alterations in brain iron concentration 
during postweaning iron deficiency in this and previous studies (Pinero et al. 2000), there are seemingly more 
subtle interactive effects exerted on the dopaminergic system than were previously appreciated. 
 
Alterations in D2 receptor functioning in iron-deficient rats has been alluded to a number of times as being 
causally related to abnormal locomotion (Youdim et al. 1989), poor home nesting behavior (Felt and Lozoff 
1995), reversal of the dark; light activity cycle (Ben-Schachar et al. 1986) and perhaps altered proprioception. 
The current study used a more pharmacologic approach to demonstrate that indeed, profound alterations in 
behavior persist despite increasing extracellular DA with large amounts of cocaine, The ED50 cocaine exper-
iment supports the concept that much higher concentrations of extracellular DA are required to have the same 
activation of locomotion as in control rats. Our previous microdialysis experiments with cocaine demonstrated 
that ID rats have higher than normal DA concentrations, both before and after cocaine administration (Nelson et 
al. 1997). The ability of cocaine to increase motor behavior demonstrates that at some functional level, all of the 
intracellular machinery and fundamental neural connections are working in the iron-deficient anemic rodent. 
The iron-deficient rats, however, never reached the same level of activity as the control rats, despite high doses 
of cocaine. This could clearly he due to fewer D1 and D2 receptors in several parts of the brain. In studies 
related to the current report, we indeed found decreased DA receptor densities in many of the same regions 
(unpublished results). Although the mechanistic relationship of local iron deficiency to DAT and receptor 
functioning remains unknown, the current report demonstrates convincingly that DAT functioning is altered in 
iron deficiency. 
 
The final set of novel observations is derived from the examination of four brain regions, which represent three 
dopaminergic tracts (nigrostriatal, mesolimbic and mesocortical) rather than only one as had been studied 
previously (Youdim et al. 1989). Because striatum is the brain region with the richest innervation of 
dopaminergic tracts, it has been the region of choice to examine iron deficiency's involvement in DA 
metabolism. The current experiments showed that although the effect of iron deficiency on the DAT is fairly 
robust, it is not universal in all parts of dopaminergic tracts. Ventral midbrain, a point of origin of the three 
dopaminergic tracts studied, was relatively unaffected with respect to a drop in iron concentration. The PFC had 
substantially less iron in the iron-deficient rats compared with controls, but had greater DAT activity. The CP 
was very sensitive to iron depletion, and as a terminal field for the mesolimbic tract, had significant changes in 
DAT activity, but only in male rats. The present report is the first to demonstrate a lower iron concentration in 
the NA as a function of dietary iron deficiency, This region also showed significantly lower DAT activity due to 
iron deficiency. The sensitivity of the CP to iron deficiency was expected on the basis of our previous data, but 
because we had not measured accumbens iron concentrations in previous studies, we did not know whether iron 
concentrations there would be affected. However, in our efforts to explore the "robustness" of the effect of iron 
deficiency on brain DA metabolism, we had to include several dopaminergic tracts. The role of these regions in 
exploratory behavior is partially what determined the behavior tests that were administered. That is, lesions in 
the caudate and the NA can decrease motor activity. Spatial learning, avoidance tasks and anxiety protocols 
would be more sensitive to alterations in other brain regions such as the PFC and hippocampus and will be 
employed in future protocols. We do not yet have the cellular detail to determine whether iron deficiency is 
more important to functioning of cell bodies or is exerting a more important role in the terminal fields of these 
dopaminergic tracts. However, the data from this experiment suggest that even very modest limitations in iron 
supply to the cell body may have an important effect on dopaminergic functioning. 
 
In conclusion, we believe that important new findings resulted from these experiments. Strong and consistent in 
vivo and in vitro data demonstrate that the DAT is only ~50% as sensitive in iron-deficient rats as control rats. 
Moreover, studies in three dopaminergic tracts revealed dissimilar effects of iron deficiency, thus demonstrating 
regional specificity of effect. That is, iron deficiency caused alterations in the nigrostriatal tract and had the 
opposite effect in the mesocortical tract. Finally, sex of the subject has a strong influence on the effect of iron 
deficiency in vitro. Behavioral studies support the concept that alterations in DA metabolism play a role in the 
behavioral outcomes of iron deficiency. Although a mechanism is still unclear, lowered DAT functioning and 
lowered DA D2 receptor density are consistent with a coupling of iron-related events. We hope to probe this 
question in subsequent studies. 
 
Notes: 
2
 Abbreviations used: CN-F, control female rats; CN-M, control male rats; CP, caudate putamen; DA, 
dopamine; DAT, dopamine transporters; ED50, half-maximal dose of drug; G8R 12935, 1-(2-
(diphenylmethoxy)-ethyl)-4-(3-pherypropyl) piperazine; GBR 12909, 1-[2-(bis[4-fluorophenyl]-
methoxyethy1]-4-[3-phenylpropy1]-piperazine; IC50, half-maximal dose of drug for in vitro effects; ID-F, iron-
deficient female rats; ID-M, iron-deficient male rats; KRH, Krebs-Ringer HEPES; NA, nucleus accumbens; 
PFC, prefrontal cortex; TIBC, total iron-binding capacity; VMB, ventral midbrain. 
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